{"id":209682,"date":"2022-10-28T13:09:02","date_gmt":"2022-10-28T13:09:02","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=209682"},"modified":"2022-10-28T13:09:02","modified_gmt":"2022-10-28T13:09:02","slug":"p-primer-trage-un-puternic-semnal-de-alarma","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=209682","title":{"rendered":"(P) PRIMER trage un puternic semnal de alarm\u0103"},"content":{"rendered":"<p>\n&nbsp;<\/p>\n<p>\n<strong><em>PRIMER <\/em><\/strong><strong>trage un <\/strong><strong>puternic <\/strong><strong>semnal de alarm\u0103: <\/strong><strong><em>\u201c<\/em><\/strong><strong><em>O parte din medicamentele fabricate \u00een tar\u0103 risc\u0103 s\u0103 dispar\u0103 \u00een cur\u00e2nd de pe pia\u0163\u0103, deoarece fabricile de medicamente ar putea fi nevoite s\u0103 opreasc\u0103 produc\u0163ia acestora, ca urmare a exploziei pre\u0163urilor, chiar \u015fi cu 300 la sut\u0103 fa\u0163\u0103 de anul trecut, la utilit\u0103\u0163i, materii prime \u015fi materiale necesare fabric\u0103rii produselor farmaceutice, \u00een lipsa unei reac\u0163ii rapide din partea autorit\u0103\u0163ilor pentru calculul pre\u0163ului la medicamente, care s\u0103 reflecte varia\u0163iile din economia real\u0103 actual\u0103<\/em><\/strong><strong><em>\u201d<\/em><\/strong><strong><em>.<\/em><\/strong><\/p>\n<p>\n<strong>PRIMER <\/strong>\u2013 care reune\u015fte cele mai importante 19 situri de fabrica\u0163ie de medicamente din \u0163ar\u0103 \u2013 atrage aten\u0163ia asupra situa\u0163iei critice cu care se confrunt\u0103 <strong>fabricile de medicamente din \u0163ar\u0103, care ar putea fi nevoite, \u00een cur\u00e2nd, s\u0103 sisteze produc\u0163ia anumitor medicamente fabricate local, din cauza cre\u015fterii explozive a costurilor cu utilit\u0103\u0163ile, materiile prime \u015fi materialele utilizate \u00een produc\u0163ia de medicamente, mai mari chiar \u015fi cu 300 la sut\u0103<\/strong>, fa\u0163\u0103 de anul trecut.<\/p>\n<p>\n<strong><em>Cre\u015fteri \u015fi de trei cifre ale pre\u0163urilor la ingrediente active farmaceutice,&nbsp; fa\u0163\u0103 de 2021.<\/em><\/strong> Astfel, pre\u0163urile ingredientelor active utilizate \u00een industria farmaceutic\u0103 au \u00eenregistrat cre\u015fteri extraordinare, comparativ cu anul anterior: Paracetamolul are un cost mai ridicat cu 278%, Carbamazepina s-a scumpit cu 197%, iar pre\u0163ul pentru Fitomenadion\u0103 (vitamina k1) a crescut cu 110%, acestea fiind doar c\u00e2teva exemple de major\u0103ri semnificative.<\/p>\n<p>\n\u00cen ceea ce prive\u015fte <strong>pre\u0163urile materiilor prime necesare fabric\u0103rii produselor farmaceutice \u015fi acestea au crescut sim\u0163itor<\/strong>, cu p\u00e2n\u0103 la <strong>150%<\/strong>, fa\u0163\u0103 de anul trecut: Amidon porumb modificat \u2013 155%; Acid benzoic \u2013 147 %; Carbonat de calciu \u2013 112%; Acid clorhidric diluat \u2013 107%; Hidroxid de sodiu \u2013 92%. Mai mult dec\u00e2t at\u00e2t, unele materii prime s-au scumpit \u015fi cu 1.570%, cum este cazul excipientului Gum\u0103 arabic\u0103, produc\u0103torii de medicamente confrunt\u00e2ndu-se, astfel, cu o situa\u0163ie generalizat\u0103 a costurilor majorate, care vizeaz\u0103 toate categoriile de materiale \u015fi materii prime folosite in industria farmaceutic\u0103.<\/p>\n<p>\nLa acestea se adaug\u0103 \u015fi presiunea <strong>scumpirilor record la energie electric\u0103&nbsp;<\/strong><strong>\u015fi gaze naturale<\/strong>, din ultimii doi ani, componente esen\u0163iale care se reflect\u0103 \u00een costurile de produc\u0163iei ale medicamentelor, cu <strong>procente n\u0103ucitoare<\/strong> de aproape 300% \u00een cazul energiei electrice, respectiv 258% pentru gaze naturale.&nbsp;&nbsp;<\/p>\n<p>\nConsecin\u0163ele negative ale acestor scumpiri uria\u015fe vor fi resim\u0163ite, mai ales, de pacien\u0163ii rom\u00e2ni, care vor fi afecta\u0163i de dispari\u0163ia anumitor medicamente din farmacii, pentru ca nu vor mai putea fi fabricate din cauza cre\u015fterii continue \u015fi tot mai accentuate a pre\u0163urilor la materiile prime \u015fi utilit\u0103\u0163i.<\/p>\n<p>\n\u00cen acest context, PRIMER solicit\u0103 autorit\u0103\u0163ilor s\u0103 intervin\u0103, fa\u0163\u0103 de toate aspectele men\u0163ionate anterior, cu <strong>m\u0103suri urgente care s\u0103 revizuiasc\u0103 modul de calcul al pre\u0163ului la medicamente, astfel \u00eenc\u00e2t, varia\u0163iile din economia real\u0103 actual\u0103 s\u0103 se reflecte \u00een pre\u0163ul medicamentului<\/strong>, pentru a sus\u0163ine continuitatea produc\u0163iei interne de medicamente precum \u015fi accesul pacien\u0163ilor rom\u00e2ni la tratamente.<\/p>\n<p>\nDin <strong>PRIMER <\/strong>fac parte cele mai importante 19 fabrici de medicamente din \u0163ar\u0103: AC HELCOR, ANTIBIOTICE, B.BRAUN, BIO-EEL SRL, BIOFARM, FITERMAN PHARMA, GEDEON-RICHTER, INFOMED FLUIDS, LABORMED-ALVOGEN, LAROPHARM, MAGISTRA CC, POLISANO PHARMACEUTICALS, ROPHARMA, SANTA SA, SLAVIA PHARM, TERAPIA \u2013 O COMPANIE SUN PHARMA, TIS PHARMACEUTICAL, VIM SPECTRUM, ZENTIVA.<\/p>\n<p>\n&nbsp;<\/p>\n<p>\n&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; PRIMER trage un puternic semnal de alarm\u0103: \u201cO parte din medicamentele fabricate \u00een tar\u0103 risc\u0103 s\u0103 dispar\u0103 \u00een cur\u00e2nd de pe pia\u0163\u0103, deoarece fabricile de medicamente ar putea fi nevoite s\u0103 opreasc\u0103 produc\u0163ia acestora, ca urmare a exploziei pre\u0163urilor, chiar \u015fi cu 300 la sut\u0103 fa\u0163\u0103 de anul trecut, la utilit\u0103\u0163i, materii prime \u015fi [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[10286,323,482,340,259],"class_list":["post-209682","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-materii-prime","tag-medicamente","tag-pret","tag-preturi","tag-productie"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/209682","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=209682"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/209682\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=209682"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=209682"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=209682"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}